Javier Ampuero

7.2k total citations
115 papers, 1.7k citations indexed

About

Javier Ampuero is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Javier Ampuero has authored 115 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 58 papers in Hepatology and 24 papers in Surgery. Recurrent topics in Javier Ampuero's work include Liver Disease Diagnosis and Treatment (86 papers), Liver Disease and Transplantation (29 papers) and Hepatitis C virus research (19 papers). Javier Ampuero is often cited by papers focused on Liver Disease Diagnosis and Treatment (86 papers), Liver Disease and Transplantation (29 papers) and Hepatitis C virus research (19 papers). Javier Ampuero collaborates with scholars based in Spain, United States and China. Javier Ampuero's co-authors include Manuel Romero‐Gómez, Rocío Gallego‐Durán, Ángela Rojas, Antonio Gil‐Gómez, Rocío Múñoz‐Hernández, K. Rajender Reddy, Carmina Montoliú, Rocío Montero‐Vallejo, Macarena Simón‐Talero and Miguel A. Serra and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Javier Ampuero

109 papers receiving 1.7k citations

Peers

Javier Ampuero
Konstantin Kazankov Denmark
Yoshio Tokumoto Japan
Miwa Kawanaka Japan
Takefumi Kimura Japan
Conrado Fernández‐Rodríguez Spain
Abdullah Al‐Osaimi United States
Raffaella Vecchione Italy
Francisco Barrera Chile
Michiharu Komatsu Japan
Monika Rau Germany
Konstantin Kazankov Denmark
Javier Ampuero
Citations per year, relative to Javier Ampuero Javier Ampuero (= 1×) peers Konstantin Kazankov

Countries citing papers authored by Javier Ampuero

Since Specialization
Citations

This map shows the geographic impact of Javier Ampuero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Ampuero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Ampuero more than expected).

Fields of papers citing papers by Javier Ampuero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Ampuero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Ampuero. The network helps show where Javier Ampuero may publish in the future.

Co-authorship network of co-authors of Javier Ampuero

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Ampuero. A scholar is included among the top collaborators of Javier Ampuero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Ampuero. Javier Ampuero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zábal, José Miguel Rosales, Manuel Rodríguez‐Perálvarez, Alberto García-García, et al.. (2025). Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C. Journal of Hepatology. 83(3). 652–661. 1 indexed citations
2.
Maya‐Miles, Douglas, et al.. (2024). MASLD biomarkers: Are we facing a new era?. Gastroenterología y Hepatología. 47(4). 393–396.
3.
Riveiro‐Barciela, Mar, Ana Barreira‐Díaz, Paula Esteban García, et al.. (2024). Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver International. 44(9). 2303–2314. 11 indexed citations
4.
Iruzubieta, Paula, Rebeca Mayo, Itziar Mincholé, et al.. (2024). One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population. United European Gastroenterology Journal. 12(7). 919–929. 8 indexed citations
5.
Ampuero, Javier, et al.. (2023). Wilson's disease: overview. Medicina Clínica (English Edition). 160(6). 261–267. 3 indexed citations
6.
Gallego, Álvaro Giráldez, Elisa Rodríguez‐Seguel, R Valencia, et al.. (2023). Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial. Gut. 73(1). 166–174. 3 indexed citations
7.
Múñoz‐Hernández, Rocío, Antonio Gil‐Gómez, R. Aller, et al.. (2023). Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. Liver International. 43(9). 1909–1919. 5 indexed citations
8.
Ballester, María Pilar, Thomas H. Tranah, Lorenz Balcar, et al.. (2023). Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis. Journal of Hepatology. 79(4). 967–976. 25 indexed citations
9.
Martínez‐Domínguez, Samuel J., Sandra G. García, Carla J. Gargallo-Puyuelo, et al.. (2023). Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals. Inflammatory Bowel Diseases. 30(8). 1274–1283. 21 indexed citations
10.
Romero‐Gómez, Manuel, R. Aller, Javier Ampuero, et al.. (2023). AEEH "Consensus about detection and referral of hidden prevalent liver diseases". Gastroenterología y Hepatología (English Edition). 46(3). 236–247. 2 indexed citations
11.
Rojas, Ángela, et al.. (2022). Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies. Journal of Clinical and Translational Hepatology. 10(2). 356–362. 16 indexed citations
12.
Tranah, Thomas H., María Pilar Ballester, Juan Antonio Carbonell‐Asins, et al.. (2022). Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis. Journal of Hepatology. 77(6). 1554–1563. 63 indexed citations
13.
Gómez‐Hurtado, Isabel, Rocío Gallego‐Durán, Pedro Zapater, et al.. (2020). Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients. Liver International. 40(9). 2182–2193. 15 indexed citations
14.
Ampuero, Javier, et al.. (2018). New therapeutic perspectives in non-alcoholic steatohepatitis. Gastroenterología y Hepatología (English Edition). 41(2). 128–142. 1 indexed citations
15.
Ampuero, Javier, et al.. (2018). Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites. Revista Española de Enfermedades Digestivas. 111(3). 223–227. 5 indexed citations
16.
Ampuero, Javier, Pablo Bellot, Rocío Gallego‐Durán, et al.. (2016). Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver International. 37(2). 212–223. 30 indexed citations
17.
Ruiz‐Margáin, Astrid, Ricardo Ulises Macías‐Rodríguez, Javier Ampuero, et al.. (2016). Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis. World Journal of Gastroenterology. 22(45). 10064–10064. 31 indexed citations
18.
Ampuero, Javier, Manuel Romero‐Gómez, & K. Rajender Reddy. (2014). Review article: HCV genotype 3 – the new treatment challenge. Alimentary Pharmacology & Therapeutics. 39(7). 686–698. 81 indexed citations
19.
Romero‐Gómez, Manuel, Ramón Planas, Javier Ampuero, et al.. (2013). Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 37(11). 1065–1073. 6 indexed citations
20.
Ampuero, Javier & Manuel Romero‐Gómez. (2012). Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular. Gastroenterología y Hepatología. 35(8). 585–593. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konstantin Kazankov Breakdown of academic impact, for papers by Yoshio Tokumoto Breakdown of academic impact, for papers by Miwa Kawanaka Breakdown of academic impact, for papers by Takefumi Kimura Breakdown of academic impact, for papers by Conrado Fernández‐Rodríguez Breakdown of academic impact, for papers by Abdullah Al‐Osaimi Breakdown of academic impact, for papers by Raffaella Vecchione Breakdown of academic impact, for papers by Francisco Barrera Breakdown of academic impact, for papers by Michiharu Komatsu Breakdown of academic impact, for papers by Monika Rau
Rankless by CCL
2026